Prokarium: Prokarium expands IP portfolio with two new US patents strengthening its position in bladder cancer
Prokarium, a biopharmaceutical company developing innovative cancer treatments, announced the receipt of two Notices of Allowance from the United States Patent and Trademark Office (USPTO). These patents,
Read full article »
Prokarium is an England-based biopharmaceutical firm that researches and develops microbial immunotherapies for the treatment of cancer.
Read more